|
AKAP11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58349999779261E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.75860009782514E-10 |
| Normal-vs-Stage2 |
4.683500E-02 |
| Normal-vs-Stage3 |
2.575000E-04 |
| Normal-vs-Stage4 |
8.224200E-03 |
| Stage1-vs-Stage2 |
2.242000E-01 |
| Stage1-vs-Stage3 |
6.849600E-01 |
| Stage1-vs-Stage4 |
9.681600E-01 |
| Stage2-vs-Stage3 |
5.189800E-01 |
| Stage2-vs-Stage4 |
4.964200E-01 |
| Stage3-vs-Stage4 |
7.885200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.20359985603613E-10 |
| Normal-vs-AfricanAmerican |
2.22489999999187E-05 |
| Normal-vs-Asian |
3.20200000003545E-06 |
| Caucasian-vs-AfricanAmerican |
5.283200E-01 |
| Caucasian-vs-Asian |
2.881400E-01 |
| AfricanAmerican-vs-Asian |
4.453900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.41310329893463E-11 |
| Normal-vs-Female |
4.875600E-03 |
| Male-vs-Female |
1.190060E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.77339999965598E-07 |
| Normal-vs-Extreme_Weight |
2.21630491736846E-11 |
| Normal-vs-Obese |
3.429700E-04 |
| Normal-vs-Extreme_Obese |
2.38979999999112E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.787200E-01 |
| Normal_Weight-vs-Obese |
1.690420E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.271400E-01 |
| Extreme_Weight-vs-Obese |
1.141920E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.720000E-01 |
| Obese-vs-Extreme_Obese |
3.333800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.90319999999944E-05 |
| Normal-vs-Age(41-60Yrs) |
1.9193000000417E-06 |
| Normal-vs-Age(61-80Yrs) |
1.15410014878137E-10 |
| Normal-vs-Age(81-100Yrs) |
4.60149995884507E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.936600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.608800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.439370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.967900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.423700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.160500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.52229945000238E-10 |
| Normal-VS-Type2 PRCC |
1.15549999568643E-08 |
| Normal-VS-KIRP CIMP |
1.590610E-04 |
| Normal-VS-Unclassified PRCC |
1.187740E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.685800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.676800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.180020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.157400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.261620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.346800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.90699719640975E-11 |
| Normal-vs-N1 |
3.515400E-03 |
| Normal-vs-N2 |
4.000900E-04 |
| N0-vs-N1 |
1.353750E-01 |
| N0-vs-N2 |
8.336400E-01 |
| N1-vs-N2 |
4.217600E-01 |
|
|
